SLC25A48
gene geneOn this page
Also known as FLJ44862
Summary
SLC25A48 (solute carrier family 25 member 48, HGNC:30451) is a protein-coding gene on chromosome 5q31.1, encoding Solute carrier family 25 member 48 (Q6ZT89). Mitochondrial transporter that transports choline across the inner mitochondrial membrane.
Predicted to enable transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to be located in mitochondrial inner membrane. Predicted to be active in mitochondrion.
Source: NCBI Gene 153328 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 28 total
- MANE Select transcript:
NM_001349336
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30451 |
| Approved symbol | SLC25A48 |
| Name | solute carrier family 25 member 48 |
| Location | 5q31.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ44862 |
| Ensembl gene | ENSG00000145832 |
| Ensembl biotype | protein_coding |
| OMIM | 616150 |
| Entrez | 153328 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 14 protein_coding, 4 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000274513, ENST00000412661, ENST00000425402, ENST00000433282, ENST00000462340, ENST00000471980, ENST00000510147, ENST00000646290, ENST00000647391, ENST00000650267, ENST00000681962, ENST00000698885, ENST00000698886, ENST00000868041, ENST00000868042, ENST00000868043, ENST00000868044, ENST00000919114, ENST00000919115
RefSeq mRNA: 4 — MANE Select: NM_001349336
NM_001349335, NM_001349336, NM_001349345, NM_145282
CCDS: CCDS43366, CCDS87323, CCDS93786
Canonical transcript exons
ENST00000681962 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001600103 | 135874021 | 135874154 |
| ENSE00001628402 | 135871461 | 135871718 |
| ENSE00003601434 | 135842416 | 135842459 |
| ENSE00003614465 | 135850425 | 135850496 |
| ENSE00003756625 | 135852563 | 135852821 |
| ENSE00003828531 | 135879968 | 135880097 |
| ENSE00003918361 | 135888032 | 135888637 |
| ENSE00003918648 | 135834663 | 135834893 |
Expression profiles
Bgee: expression breadth ubiquitous, 169 present calls, max score 93.70.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.9275 / max 186.4196, expressed in 177 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 58662 | 0.5135 | 115 |
| 58656 | 0.2308 | 86 |
| 58657 | 0.0741 | 31 |
| 58659 | 0.0473 | 16 |
| 58658 | 0.0325 | 12 |
| 58655 | 0.0294 | 10 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibial nerve | UBERON:0001323 | 93.70 | gold quality |
| sural nerve | UBERON:0015488 | 90.98 | gold quality |
| amygdala | UBERON:0001876 | 86.68 | gold quality |
| tibia | UBERON:0000979 | 85.65 | gold quality |
| hypothalamus | UBERON:0001898 | 84.84 | gold quality |
| caudate nucleus | UBERON:0001873 | 84.68 | gold quality |
| putamen | UBERON:0001874 | 83.59 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 83.15 | gold quality |
| right frontal lobe | UBERON:0002810 | 82.66 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 82.03 | gold quality |
| prefrontal cortex | UBERON:0000451 | 81.75 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 81.66 | gold quality |
| substantia nigra | UBERON:0002038 | 81.23 | gold quality |
| spinal cord | UBERON:0002240 | 80.68 | gold quality |
| nucleus accumbens | UBERON:0001882 | 80.49 | gold quality |
| Ammon’s horn | UBERON:0001954 | 79.98 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 79.57 | gold quality |
| metanephros cortex | UBERON:0010533 | 79.44 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.28 | silver quality |
| midbrain | UBERON:0001891 | 78.64 | gold quality |
| pancreatic ductal cell | CL:0002079 | 78.48 | silver quality |
| neocortex | UBERON:0001950 | 78.10 | gold quality |
| frontal cortex | UBERON:0001870 | 78.08 | gold quality |
| oocyte | CL:0000023 | 77.82 | gold quality |
| temporal lobe | UBERON:0001871 | 77.45 | gold quality |
| cerebral cortex | UBERON:0000956 | 77.11 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 75.84 | gold quality |
| forebrain | UBERON:0001890 | 75.49 | gold quality |
| ileal mucosa | UBERON:0000331 | 74.75 | gold quality |
| corpus callosum | UBERON:0002336 | 74.69 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.65 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting SLC25A48, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-3191-5P | 99.24 | 66.52 | 1722 |
| HSA-MIR-544B | 99.18 | 67.41 | 1632 |
| HSA-MIR-5190 | 99.15 | 67.76 | 1234 |
| HSA-MIR-3117-5P | 99.04 | 67.93 | 618 |
| HSA-MIR-5094 | 98.63 | 67.11 | 1062 |
| HSA-MIR-4463 | 98.56 | 66.05 | 1071 |
| HSA-MIR-4443 | 98.02 | 66.25 | 1928 |
| HSA-MIR-432-5P | 98.00 | 68.13 | 989 |
| HSA-MIR-219B-5P | 97.91 | 65.80 | 531 |
| HSA-MIR-6515-5P | 97.08 | 65.48 | 1219 |
| HSA-MIR-3194-5P | 96.80 | 64.90 | 1027 |
| HSA-MIR-3907 | 96.76 | 65.04 | 662 |
Literature-anchored findings (GeneRIF, showing 4)
- Compares and contrasts all the known human SLC25A* genes and includes functional information. (PMID:23266187)
- Metabolic gene function discovery platform GeneMAP identifies SLC25A48 as necessary for mitochondrial choline import. (PMID:38977856)
- SLC25A48 influences plasma levels of choline and localizes to the inner mitochondrial membrane. (PMID:39047301)
- SLC25A48 controls mitochondrial choline import and metabolism. (PMID:39111307)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc25a48 | ENSDARG00000021250 |
| mus_musculus | Slc25a48 | ENSMUSG00000021509 |
| rattus_norvegicus | Slc25a48 | ENSRNOG00000012040 |
Paralogs (49): SLC25A13 (ENSG00000004864), SLC25A5 (ENSG00000005022), SLC25A39 (ENSG00000013306), SLC25A40 (ENSG00000075303), SLC25A3 (ENSG00000075415), SLC25A43 (ENSG00000077713), SLC25A24 (ENSG00000085491), SLC25A1 (ENSG00000100075), SLC25A17 (ENSG00000100372), SLC25A14 (ENSG00000102078), SLC25A15 (ENSG00000102743), SLC25A11 (ENSG00000108528), UCP1 (ENSG00000109424), SLC25A36 (ENSG00000114120), SLC25A12 (ENSG00000115840), SLC25A2 (ENSG00000120329), SLC25A51 (ENSG00000122696), SLC25A16 (ENSG00000122912), SLC25A35 (ENSG00000125434), SLC25A19 (ENSG00000125454), SLC25A23 (ENSG00000125648), SLC25A47 (ENSG00000140107), SLC25A52 (ENSG00000141437), SLC25A38 (ENSG00000144659), SLC25A26 (ENSG00000144741), SLC25A37 (ENSG00000147454), SLC25A25 (ENSG00000148339), SLC25A31 (ENSG00000151475), SLC25A4 (ENSG00000151729), SLC25A27 (ENSG00000153291), SLC25A28 (ENSG00000155287), SLC25A44 (ENSG00000160785), SLC25A45 (ENSG00000162241), SLC25A34 (ENSG00000162461), SLC25A32 (ENSG00000164933), SLC25A6 (ENSG00000169100), SLC25A33 (ENSG00000171612), SLC25A30 (ENSG00000174032), UCP3 (ENSG00000175564), UCP2 (ENSG00000175567)
Protein
Protein identifiers
Solute carrier family 25 member 48 — Q6ZT89 (reviewed: Q6ZT89)
All UniProt accessions (6): A0A3B3IRS1, A0A3B3IS12, C9JM56, D6RFW8, Q6ZT89, J3KQI1
UniProt curated annotations — full annotation on UniProt →
Function. Mitochondrial transporter that transports choline across the inner mitochondrial membrane.
Subcellular location. Mitochondrion membrane. Mitochondrion inner membrane.
Similarity. Belongs to the mitochondrial carrier (TC 2.A.29) family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZT89-1 | 1 | yes |
| Q6ZT89-2 | 2 | |
| Q6ZT89-3 | 3 |
RefSeq proteins (4): NP_001336264, NP_001336265, NP_001336274, NP_660325 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002067 | MCP | Family |
| IPR018108 | MCP_transmembrane | Repeat |
| IPR023395 | MCP_dom_sf | Homologous_superfamily |
| IPR050567 | Mitochondrial_Carrier | Family |
Pfam: PF00153
Catalyzed reactions (Rhea), 1 shown:
- choline(out) = choline(in) (RHEA:32751)
UniProt features (16 total): transmembrane region 6, splice variant 3, mutagenesis site 3, repeat 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZT89-F1 | 75.59 | 0.01 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (3):
| Position | Phenotype |
|---|---|
| 27 | does not affect mitochondrion membrane localization. impairs mitochondrial choline uptake. |
| 64 | does not affect mitochondrion membrane localization. impairs mitochondrial choline uptake. |
| 179 | reduction of mitochondrial localization. impairs mitochondrial choline uptake. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 51 (showing top):
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP, MARTINEZ_RB1_TARGETS_UP, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_ORGANIC_CATION_TRANSPORT, MARTINEZ_RB1_AND_TP53_TARGETS_UP, GOBP_TRANSMEMBRANE_TRANSPORT, chr5q31, GOCC_ORGANELLE_INNER_MEMBRANE, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7, GOMF_TRANSPORTER_ACTIVITY, GOCC_ORGANELLE_ENVELOPE, GOBP_CHOLINE_TRANSPORT, MAFG_TARGET_GENES, ZNF257_TARGET_GENES, ZSCAN31_TARGET_GENES
GO Biological Process (2): choline transport (GO:0015871), transmembrane transport (GO:0055085)
GO Molecular Function (3): choline transmembrane transporter activity (GO:0015220), transmembrane transporter activity (GO:0022857), protein binding (GO:0005515)
GO Cellular Component (4): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020), mitochondrial membrane (GO:0031966)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nitrogen compound transport | 1 |
| transport | 1 |
| cellular process | 1 |
| choline transport | 1 |
| transmembrane transporter activity | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cellular anatomical structure | 1 |
| mitochondrion | 1 |
| mitochondrial envelope | 1 |
| organelle membrane | 1 |
Protein interactions and networks
STRING
754 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC25A48 | SLC25A52 | Q3SY17 | 494 |
| SLC25A48 | SLC25A51 | Q9H1U9 | 479 |
| SLC25A48 | SLC25A46 | Q96AG3 | 467 |
| SLC25A48 | SLC16A9 | Q7RTY1 | 457 |
| SLC25A48 | TXNDC15 | Q96J42 | 452 |
| SLC25A48 | SLC16A5 | O15375 | 447 |
| SLC25A48 | SLC25A53 | Q5H9E4 | 430 |
| SLC25A48 | TTC23 | Q5W5X9 | 422 |
| SLC25A48 | CATSPER3 | Q86XQ3 | 410 |
| SLC25A48 | SNAPC1 | Q16533 | 373 |
| SLC25A48 | BCKDK | O14874 | 357 |
| SLC25A48 | ABTB3 | A6QL63 | 349 |
| SLC25A48 | MLF1 | P58340 | 340 |
| SLC25A48 | PDPR | Q8NCN5 | 336 |
| SLC25A48 | MIOX | Q9UGB7 | 329 |
IntAct
22 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP10-7 | SLC25A48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAF1 | SLC25A48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC25A48 | PNMA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBASH3B | SLC25A48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC25A48 | MID2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC25A48 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| SLC25A48 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MID2 | SLC25A48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC25A48 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| SLC25A48 | UBASH3B | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNMA1 | SLC25A48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HMGA1 | SLC25A48 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SLC25A48 | TPM2 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC25A48 | TXNDC9 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (39): SLC25A48 (Two-hybrid), SLC25A48 (Two-hybrid), SLC25A48 (Two-hybrid), SLC25A48 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-3 (Two-hybrid), TPM2 (Affinity Capture-MS), RNF11 (Affinity Capture-MS), EEF2 (Affinity Capture-MS), ANKRD40 (Affinity Capture-MS), SLC25A48 (Affinity Capture-MS), SLC25A48 (Two-hybrid), SLC25A48 (Two-hybrid), SLC25A48 (Two-hybrid), SLC25A48 (Two-hybrid)
ESM2 similar proteins: A0A0U2IR85, A0A3G9HRV8, A4RF23, A5DIS9, F4HW79, G3YC86, G3YD89, G3YFS7, K3VFR5, K7VYZ9, O13844, O60029, O81845, O94370, P04710, P23500, P31692, P32331, P32332, P38152, P38921, P40035, Q03028, Q06143, Q10248, Q12289, Q12375, Q18P97, Q54B67, Q54BM3, Q54FE6, Q55GE2, Q6C107, Q6FTN2, Q6ZT89, Q7DNC3, Q84UC7, Q86AV5, Q8BW66, Q8CFJ7
Diamond homologs: A0A0G2K5L2, A2ADF7, A4QNX2, B0G143, F1LX07, F1LZW6, F1RFX9, O13844, O43772, O75746, P16261, P39953, Q02978, Q08DK4, Q0II44, Q12482, Q1DRJ3, Q21153, Q26365, Q3KQZ1, Q3TZX3, Q4V8K4, Q505J6, Q54QN2, Q54RB9, Q552L9, Q58DS3, Q5B717, Q5RBC8, Q5RD81, Q5SWT3, Q5XIF9, Q5ZKP7, Q66L49, Q68F18, Q6ZT89, Q75AH6, Q7PQV7, Q86AV5, Q8BH59
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
28 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 18 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1986 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:135574566:GCGTA:G | donor_loss | 1.0000 |
| 5:135574567:CGTA:C | donor_loss | 1.0000 |
| 5:135574568:GTAC:G | donor_loss | 1.0000 |
| 5:135574569:TACC:T | donor_loss | 1.0000 |
| 5:135574570:A:C | donor_loss | 1.0000 |
| 5:135574571:CCTGC:C | donor_loss | 1.0000 |
| 5:135578428:ACTC:A | donor_loss | 1.0000 |
| 5:135578430:TCA:T | donor_loss | 1.0000 |
| 5:135578432:A:AC | donor_gain | 1.0000 |
| 5:135578433:C:CC | donor_gain | 1.0000 |
| 5:135578433:CATAA:C | donor_gain | 1.0000 |
| 5:135578437:A:C | donor_gain | 1.0000 |
| 5:135578536:GACCC:G | acceptor_loss | 1.0000 |
| 5:135578540:C:CC | acceptor_gain | 1.0000 |
| 5:135578540:CTGC:C | acceptor_loss | 1.0000 |
| 5:135578541:T:A | acceptor_loss | 1.0000 |
| 5:135834890:GGAG:G | donor_gain | 1.0000 |
| 5:135834891:GAG:G | donor_gain | 1.0000 |
| 5:135834891:GAGG:G | donor_gain | 1.0000 |
| 5:135834894:G:C | donor_loss | 1.0000 |
| 5:135834894:G:GG | donor_gain | 1.0000 |
| 5:135850423:A:AG | acceptor_gain | 1.0000 |
| 5:135850424:G:GG | acceptor_gain | 1.0000 |
| 5:135850493:GAGT:G | donor_gain | 1.0000 |
| 5:135850495:GT:G | donor_gain | 1.0000 |
| 5:135850497:G:GG | donor_gain | 1.0000 |
| 5:135852817:GGACG:G | donor_gain | 1.0000 |
| 5:135852818:GACG:G | donor_gain | 1.0000 |
| 5:135852818:GACGG:G | donor_gain | 1.0000 |
| 5:135852820:CGGTA:C | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000011934 (5:135651077 G>A,C), RS1000025653 (5:135776274 G>A,C,T), RS1000030070 (5:135858918 G>C), RS1000035649 (5:135803529 T>C), RS1000040909 (5:135786298 TG>T), RS1000048899 (5:135638210 G>A,T), RS1000057718 (5:135873489 G>A,C), RS1000060347 (5:135808004 T>C), RS1000077787 (5:135790550 G>A), RS1000088330 (5:135701763 A>G), RS1000107383 (5:135834364 A>T), RS1000109610 (5:135873751 A>T), RS1000115875 (5:135599222 C>A,T), RS1000134397 (5:135732504 C>G), RS1000150218 (5:135764809 T>G)
Disease associations
OMIM: gene MIM:616150 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_688 | Obesity-related traits | 3.000000e-06 |
| GCST004689_1 | Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous) | 7.000000e-08 |
| GCST004690_1 | Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous) | 6.000000e-08 |
| GCST006992_1 | Cerebrospinal fluid p-tau levels in Alzheimer’s disease dementia | 8.000000e-07 |
| GCST007007_2 | Cerebrospinal fluid t-tau levels | 2.000000e-07 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004810 | interleukin-6 measurement |
| EFO:0008307 | tuberculin skin test reactivity measurement |
| EFO:0008322 | decreased susceptibility to bacterial infection |
| EFO:0004763 | p-tau measurement |
| EFO:0004760 | t-tau measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs7716492 | CXCL14, SLC25A48 | 0.00 | 0 |
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — Miscellaneous SLC25 mitochondrial transporters
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression | 3 |
| Methapyrilene | decreases expression, increases methylation | 2 |
| Valproic Acid | increases expression, increases methylation | 2 |
| Aflatoxin B1 | decreases expression, decreases methylation | 2 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| maleic acid | increases expression | 1 |
| Air Pollutants | affects methylation, increases abundance | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Nicotine | decreases expression | 1 |
| Nitrogen Dioxide | increases abundance, affects methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
| Particulate Matter | affects methylation, increases abundance | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4KD | HCT116-SLC25A48-KO-c10 | Cancer cell line | Male |
| CVCL_D4KE | HCT116-SLC25A48-KO-c11 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.